Intra-Articular PRP Versus Dexamethasone for TMJ Internal Derangement
Evaluation of the Efficacy of Intra-Articular Injection of Platelet-Rich Plasma Versus Dexamethasone With Local Anaesthetic in the Treatment of Internal Derangement of the Temporomandibular Joint: A Randomised Controlled Trial
2 other identifiers
interventional
30
1 country
1
Brief Summary
This study looked at whether an injection into the jaw joint (temporomandibular joint, or TMJ) can help people who have pain, clicking, and difficulty opening their mouth due to a slipped joint disc. Thirty patients were randomly assigned to receive one of three injections: platelet-rich plasma (PRP, made from the patient's own blood), a steroid medication (dexamethasone) with a local anesthetic, or a saline (salt water) injection as a comparison. Pain, joint clicking, and mouth opening were measured before the injection and one week later. The study found that both PRP and the steroid injection reduced pain and clicking more than saline, and PRP also improved how wide patients could open their mouth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 9, 2026
CompletedFirst Submitted
Initial submission to the registry
July 2, 2026
CompletedFirst Posted
Study publicly available on registry
July 9, 2026
CompletedJuly 9, 2026
July 1, 2026
4 months
July 2, 2026
July 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Pain Intensity (VAS)
Pain intensity rated on a 10-cm visual analogue scale (0=no pain, 10=worst imaginable pain), reflecting the most intense pain during function.
Baseline and 1 week post-injection
Secondary Outcomes (2)
Change in Joint Sound (Clicking)
Baseline and 1 week post-injection
Change in Maximum Interincisal Opening (MIO)
Baseline and 1 week post-injection
Study Arms (3)
PRP
EXPERIMENTALSingle intra-articular injection of 0.6 mL leukocyte-poor platelet-rich plasma (PRP) into the superior joint space via a preauricular approach.
Dexamethasone + Local Anaesthetic
ACTIVE COMPARATORSingle intra-articular injection of dexamethasone 4 mg (0.5 mL) combined with lidocaine 2% (0.5 mL), total 1 mL, into the superior joint space.
Normal Saline (Control)
PLACEBO COMPARATORSingle intra-articular injection of 1 mL sterile 0.9% sodium chloride into the superior joint space, replicating the full procedural experience without an active agent.
Interventions
Autologous platelet-rich plasma (1 mL) prepared from the patient's own venous blood by centrifugation, injected into the superior joint space of the temporomandibular joint under a standardised preauricular approach.
Intra-articular injection (1 mL) of dexamethasone combined with a local anaesthetic, delivered into the superior joint space of the temporomandibular joint using the same standardised preauricular approach as the other study arms.
Intra-articular injection (1 mL) of normal saline solution into the superior joint space of the temporomandibular joint, serving as the placebo control, using the same standardised preauricular approach as the other study arms.
Eligibility Criteria
You may qualify if:
- Skeletally mature patients aged 18 years or older
- Symptomatic TMJ internal derangement in the form of disc displacement with reduction (DDwR), diagnosed using DC/TMD Axis I clinical criteria
- TMJ arthralgia confirmed by pain reproduced on palpation or provoked by jaw movement
- Clicking sound detectable on palpation or auscultation during opening and closing movements
- Elimination or marked reduction of the click on mouth opening from a protruded position
You may not qualify if:
- Intra-articular injection within the previous six months
- Systemic inflammatory arthropathy
- Coagulopathy
- Active local infection
- Low platelet count
- Ongoing antiplatelet or anticoagulant therapy
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Dentistry, University of Anbar
Ramadi, Al Najaf, 54001, Iraq
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sabah Alheeti, BDS, CABMS, FIBMS
Oral and Maxillofacial Surgery Department / College of Dentistry / University of Anbar
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- "Outcome assessor was fully blinded throughout follow-up. Participants in the dexamethasone and saline arms were blinded to allocation; full blinding was not feasible in the PRP arm due to the visible blood-draw and processing procedure
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postgraduate Researcher
Study Record Dates
First Submitted
July 2, 2026
First Posted
July 9, 2026
Study Start
December 10, 2025
Primary Completion
April 9, 2026
Study Completion
April 9, 2026
Last Updated
July 9, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
"The dataset supporting the conclusions of this article may be requested from the corresponding author"